✦ LIBER ✦

Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab′ certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension

✍ Scribed by K. Reich; J.-P. Ortonne; A.B. Gottlieb; I.J. Terpstra; G. Coteur; C. Tasset; P. Mease

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy (PASI 90 and global

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Secukinumab treatment shows a neutral ef

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

CLinical experience acquired with the ef

✍ L. Dubertret; W. Sterry; J.D. Bos; S. Chimenti; S. Shumack; C.G. Larsen; N.H. Sh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

Safety and efficacy of subcutaneous cert

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Safety of efalizumab in adults with chro

✍ Kim A. Papp; Reni Bressinck; Scott Fretzin; Bernard Goffe; Steven Kempers; Kenne 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Efficacy and safety of secukinumab in th

✍ Papp, K.A.; Langley, R.G.; Sigurgeirsson, B.; Abe, M.; Baker, D.R.; Konno, P.; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB